TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, "Titan Medical Inc.”) ("the "Resulting Issuer” or the "Corporation”) (TSX: TMD; OTC: TMDIF) is pleased to announce the completion of the previously announced business combination between Conavi Medical Inc. ("Conavi”) and the Corporation in an all-stock transaction, which constituted a reverse takeover of the Corporation (the "Transaction”). The combined company (the Resulting Issuer) will focus on continuing to commercialize and develop Conavi's Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.

Completion of Concurrent Financing

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here